Nurix Therapeutics NRIX - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Options

Nurix Therapeutics Inc (NRIX)

17.57

0.26

(1.50%)

Closed 14 February 8:00AM

Delayed by 15 minutes

17.57

0.00

( 0.00% )

Pre Market: 8:09PM

Delayed by 15 minutes

NRIX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	8.00	11.90	0.00	9.95	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	3.90	6.80	7.50	5.35	0.00	0.00 %	0	1	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	1.25	1.65	1.25	1.45	0.00	0.00 %	0	1,109	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.10	0.40	0.10	0.25	0.00	0.00 %	0	142	-
30.00	0.10	0.10	0.10	0.10	0.00	0.00 %	0	12	-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.15	2.05	0.15	1.10	0.00	0.00 %	0	6	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	1.55	3.70	0.00	2.625	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	5.60	9.00	7.00	7.30	0.00	0.00 %	0	0	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRPXVirpax Pharmaceuticals Inc	US$ 0.5267 (82.31%)	5.82M
MBRXMoleculin Biotech Inc	US$ 2.13 (67.72%)	9.94M
STAIScanTech AI Systems Inc	US$ 2.34 (39.29%)	1.68M
DXRDaxor Corporation	US$ 9.92 (39.13%)	10
LGHLWLion Group Holding Ltd	US$ 0.0093 (36.78%)	1
ISPOInspirato Inc	US$ 2.01 (-55.82%)	1
FTQIFirst Trust Exchange Traded Fund VI Nasdaq BuyWrite Income ETF	US$ 11.01 (-48.26%)	3
MYNAMynaric AG	US$ 0.2377 (-43.94%)	546.49k
BLACBellevue Life Sciences Acquisition Corporation	US$ 4.05 (-42.55%)	456
INNVInnovAge Holding Corporation	US$ 2.01 (-41.91%)	1
CNSPCNS Pharmaceuticals Inc	US$ 0.1455 (34.97%)	20.43M
MBRXMoleculin Biotech Inc	US$ 2.13 (67.72%)	9.94M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5267 (82.31%)	5.82M
CYNCYNGN Inc	US$ 0.0946 (-9.90%)	2.13M
MGOLMGO Global Inc	US$ 0.8105 (-4.08%)	2.1M

Monksdream

Monksdream 4 months ago

NRIX 10Q due Oct 17

Monksdream

Monksdream 4 months ago

NRIX 10 Q due 10 October

Monksdream

Monksdream 5 months ago

NRIX creeping higher

Monksdream

Monksdream 7 months ago

NRIX 10 Q expected JULY11

Monksdream

Monksdream 8 months ago

NRIX new 52 week high

Monksdream

Monksdream 8 months ago

NRIX more new highs up ahead

Monksdream

Monksdream 10 months ago

Monksdream

Monksdream 10 months ago

Monksdream

Monksdream 11 months ago

NRIX new 52 week high

TheFinalCD

TheFinalCD 2 years ago

https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/88898489/cathie-wood-doubles-down-on-these-2-strong-buy

infamous

infamous 4 years ago

what the F is wrong with this fkn stock? does it ever go up???

Phosphene

Phosphene 4 years ago

CEO: Dr. Arthur T. Sands

https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/

Phosphene

Phosphene 4 years ago

Strategic partnerships with Sanofi and Gilead Sciences Inc.

https://www.nurixtx.com/research-development/strategic-partnerships/

Wellington and Baker Brothers are among Institutional Ownership and Shareholders:

https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA

Phosphene

Phosphene 4 years ago

Data support a planned clinical trial of NX-2127 in B-cell malignancies

http://www.globenewswire.com/news-release/2020/12/07/2140737/0/en/Nurix-Therapeutics-Presents-Preclinical-Data-at-62nd-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html

Nurix Therapeutics

Metal Management

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions